[Lack of anti-Mullerian factor in a male].

K Boczkowski(Medical University of Warsaw), E. Mickiewicz(University of Chicago), W Joszt, Z Kaliciński

PubMed

October 1, 1972

Cited by 0

Related Papers

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

|New England Journal of Medicine|2004|1.8k

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

|New England Journal of Medicine|2007|1.7k

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

|The Lancet|2007|912

Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial

|Journal of Clinical Oncology|2000|318

LEVAMISOLE IN ADVANCED HUMAN BREAST CANCER

|The Lancet|1976|159